Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05335369 · ClinicalTrials.gov registry record · NA
A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
NCT05335369 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 161 participants.
The verdict
NCT05335369, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the preliminary efficacy of the UR-GOAL tool in improving shared decision making and communication between older patients with AML and their oncologists in a pilot randomized trial.
Interventions
- BEHAVIORAL UR-GOAL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2022-06-17 |
| Est. Completion | 2025-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05335369
The ClinicalTrials.gov registry entry for NCT05335369 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which UR-GOAL is the first listed.
NCT05335369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05335369 about?
NCT05335369 is a clinical study titled "A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists". The objective of this study is to evaluate the preliminary efficacy of the UR-GOAL tool in improving shared decision making and communication between older patients with AML and their oncologists in a pilot randomized trial.
What is the current status of trial NCT05335369?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2022-06-17. Estimated completion is 2025-10-06.
What interventions are being tested in trial NCT05335369?
The interventions under investigation include: UR-GOAL (BEHAVIORAL).
Who is sponsoring clinical trial NCT05335369?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.